Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Expansion of Specialty Intermediates Facility
Funding capital expenditure for expanding manufacturing capacity at the Specialty Intermediates plant.
Fluorospecialty Chemical Plant Setup
Investment in wholly-owned subsidiary Yellowstone Fine Chemicals for setting up a fluorospecialty chemical manufacturing facility.
Prepayment or Repayment of Outstanding Borrowings
Prepayment or repayment of debt incurred by the company and its subsidiary Viva Lifesciences.
Working Capital Requirements
Funding working capital needs of the company and subsidiary Yellowstone Fine Chemicals.
Purchase of Plant and Machinery
Acquiring plant and machinery to bolster infrastructure at the SI manufacturing facility.
No documents added yet.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
Laxmi Organic Industries Limited is a leading Indian specialty chemicals manufacturer focused on acetyl intermediates and diketene derivatives. Incorporated in 1989, the company has established a commanding presence in the domestic chemical sector, operating as one of India's largest producers of ethyl acetate and the sole domestic manufacturer of diketene derivatives. Its diverse product portfolio serves critical global supply chains across pharmaceuticals, agrochemicals, printing inks, dyes, pigments, and industrial coatings. The company operates state-of-the-art manufacturing facilities located in Mahad, Maharashtra. To strengthen its technology capabilities and expand into high-value chemical domains, Laxmi Organic acquired the business assets and intellectual property of Miteni, an Italian fluorospecialty chemicals manufacturer. This strategic expansion enabled the company to enter the advanced fluorospecialty market, diversifying its revenue streams beyond traditional acetyl building blocks. Laxmi Organic maintains long-standing relationships with leading multinational corporations and domestic blue-chip companies across more than 30 countries. Supported by dedicated research and development centers and robust quality assurance systems, the organization continues to enhance operational efficiency, increase manufacturing capacities, and capitalize on expanding global demand for specialty chemical intermediates.
Laxmi Organic raised ₹180.00 crore by allocating 1,38,46,153 equity shares to 15 anchor investors at ₹130 per share. Prominent anchor investors included Abu Dhabi Investment Authority, Nomura India Equity Fund, SBI Mutual Fund, ICICI Prudential Mutual Fund, Kotak Mutual Fund, Aditya Birla Sun Life Mutual Fund, and Ashoka India Opportunities Fund.
Source: RHP • Analysis provided for informational purposes
Last Updated: 28 July 2026, 7:28 AM
Domestic Leadership in Diketene Derivatives
Positioned as India's sole manufacturer of diketene derivatives with significant market share in essential specialty chemical building blocks.
Largest Indian Exporter of Ethyl Acetate
Operates as a leading supplier and exporter of ethyl acetate, benefitting from large-scale manufacturing infrastructure and cost competitiveness.
Diversified Global Client Network
Serves a broad customer base across major global markets, supporting critical supply chains in pharmaceuticals, agrochemicals, and industrial coatings.
Raw Material Price Volatility
Fluctuations in key feedstock costs such as acetic acid and ethanol can impact operating margins if cost changes cannot be passed to customers.
Environmental and Regulatory Compliance
Chemical manufacturing operations are subject to strict environmental regulations, requiring ongoing capital investments in compliance and waste management.
Laxmi Organic Industries Limited
Chandermukhi Building, 2nd and 3rd Floor, Nariman Point, Mumbai - 400021, Maharashtra, India
View on Maps →MUFG Intime India Private Limited
No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.